Reverse transcriptase-polymerase chain reaction for bcr/abl fusion in chronic myelogenous leukemia

American Journal of Clinical Pathology

Volumn 105, Issue 6, 1996, Pages 756-760

  Wells, Stephen J ^a   Phillips, Carol N ^a   Winton, Elliot F ^a   Farhi, And Diane C ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

bcr abl; Bone marrow transplantation; Chronic myelogenous leukemia; Philadelphia chromosome; Polymerase chain reaction; Reverse transcriptase

Indexed keywords

ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; HUMAN; KARYOTYPING; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029924840     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.6.756     Document Type: Article

References (26)

1. Rowley JD. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973;243:290-295.
2. Bartram CR, deKLein A, Hagemëyer A, et al. Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukemia. Nature 1983; 306:277-280.
3. Groffen J, Stephenson JR, Heisterkamp N, deKlein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984;36:93-99.
4. Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med 1988;319:990-998.
5. Rowley JD. Ph1-positive leukemia including chronic myelogenous leukemia. Clin Haematol 1980;9:55-86.
6. Kawasaki ES, Clark SS, Coune MY, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85:5698-5702.
7. Southern LM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975;98:503-517.
8. Mitelman F, ed. Guidelines for Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger, 1991.
9. Lee M, Kantarjian H, Talpaz M, et al. Detection of minimal residual disease by polymerase chain reaction in Philadelphia chromosome-positive chronic myelogenous leukemia following interferon therapy. Blood 1992;79:1920-1923.
10. Opalka B, Wandl UB, Becher R, et al. Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2B alone or in combination with interferon γ. Blood 1991;78:2188-2193.
11. Yoffe G, Blick M, Kantarjian H, Spitzer G, Gutterman J, Talpaz M. Molecular analysis of interferon-induced suppression of Philadelphia chromosome in patients with chronic myeloid leukemia. Blood 1987;69:961-963.
12. Opalka B, Kloke O, Bartram CR, et al. Elimination by interferon-α of malignant clone in chronic myeloid leukaemia (Letter). Lancet 1989;1:1334.
13. Talpaz M, Kantarjian H, Kurzrock R, Truijillo JM, Gutterman JU. Interferon-α produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 1991;114: 532-538.
14. Roth MS, Anti JH, Bingham EM, Ginsberg D. Detection of Philadelphia chromomose-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989;74:882-885.
15. Roth MS, Antin JH, Ash R, et al. Prognostic significance of Philadelphia chromosome-positve cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992;79:276-282.
16. Gabert J, Lafage M, Maraninchi D, Thuret I, Carcassone Y, Mannoni P. Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Lancet 1989;2:1125-1128.
17. Sawyers CL, Timson T, Kawasaki ES, Clark SS, Witte ON. Champlin R. Molecular relpase in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction. Proc Natl Acad Sci USA 1990;87: 563-567.
18. Delfau M-H, Kerckaert J-P, d'Hooghe MC, et al. Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Leukemia 1990;4:1-5.
19. Hughes T, Martiat P, Morgan G, Sawyers C, Witte JM. Significance of residual leukaemia transcripts after bone marrow transplant for CML (Letter). Lancet 1990;335:50.
20. Hughes T, Morgan GJ, Martiat P, Goldman JM. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 1991;77:874-878.
21. Martiat P, Maisin D, Philippe M, et al. Detection of residual bcr/ abl transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. Br J Haematol 1990;75:355-358.
22. Pignon JM, Henni T, Amselem S, et al. Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 1990;4:83-86.
23. Lange W, Herkert R, Finke J, et al. Apparent decrease and elimination of bcr/abl mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Ann Hematol 1991;63:189-194.
24. Guerrasio A, Martinelli G, Saglio G, et al. Minimal residual disease status in transplanted chronic myelogenous leukemia patients: Low incidence of polymerase chain reaction positive cases among 48 long disease-free subjects who received ummanipulated allogeneic bone marrow transplants. Leukemia 1992;6: 507-512.
25. Lee M, Khouri I, Champlin R, et al. Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation. Br J Haematol 1992;82:708-714.
26. Westbrook CA. The role of molecular techniques in the clinical managment of leukemia: Lessons from the Philadelphia chromosome. Cancer 1992; 70(suppl):1695-1700.